• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶栓治疗的脑卒中患者的血管性水肿。

Angioedema in Stroke Patients With Thrombolysis.

机构信息

From the Department of Neurology (K.F., K.M., S.T.G., T.B., M.J.H., S.S., F.S., B.K., K.W.), University Hospital Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Germany.

Department of Neuroradiology (M.S., A.D.), University Hospital Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Germany.

出版信息

Stroke. 2019 Jul;50(7):1682-1687. doi: 10.1161/STROKEAHA.119.025260. Epub 2019 Jun 11.

DOI:10.1161/STROKEAHA.119.025260
PMID:31182002
Abstract

Background and Purpose- Oral angioedema (OA) is a rare but life-threatening complication in patients with ischemic stroke receiving intravenous thrombolysis with r-tPA (recombinant tissue-type plasminogen activator). This study intended to determine associations between thrombolysis-related OA and ischemic stroke lesion sites using a voxel-wise lesion analysis. Methods- Prospective registry data were used to identify ischemic stroke patients with thrombolysis-related OA between 2002 and 2018. For the study registry, ethics approval was obtained by the Ethics Committee of the Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg (clinical registry registration: 377_17Bc). Ischemic stroke patients with thrombolysis treatment but without OA admitted in the years 2011 and 2012 comprised the control group. Ischemic lesions were manually outlined on magnetic resonance imaging (1.5T or 3T) or computed tomographic scans and transformed into stereotaxic space. We determined the lesion overlap and compared the absence or presence of OA voxel-wise between patients with and without lesions in a given voxel using the Liebermeister test. Stroke severity was rated using the National Institutes of Health Stroke Scale score, and blood pressure, heart rate, blood glucose levels, and body temperature were determined on admission. Results- Fifteen ischemic stroke patients with thrombolysis-related OA were identified. The voxel-wise analysis yielded associations between OA and ischemic lesions in the insulo-opercular region with a right hemispheric dominance. Mean blood pressure was significantly lower in patients with OA than in controls. Age, National Institutes of Health Stroke Scale scores, infarct volumes, heart rate, and blood glucose levels did not differ between patients with and without OA. Conclusions- The voxel-wise analysis linked thrombolysis-related OA to right insulo-opercular lesions. The lower blood pressure in patients with thrombolysis-related OA may reflect bradykinin effects causing vasodilatation and increasing vascular permeability.

摘要

背景与目的- 接受 r-tPA(重组组织型纤溶酶原激活剂)静脉溶栓治疗的缺血性脑卒中患者会发生口腔血管性水肿(OA),这是一种罕见但危及生命的并发症。本研究旨在使用体素分析方法确定溶栓相关 OA 与缺血性脑卒中病变部位之间的相关性。方法- 使用前瞻性注册数据确定了 2002 年至 2018 年期间接受溶栓治疗的伴有溶栓相关 OA 的缺血性脑卒中患者。该研究的注册数据已获得 Friedrich-Alexander-Universität(FAU)Erlangen-Nürnberg 伦理委员会的批准(临床注册登记号:377_17Bc)。2011 年和 2012 年未发生 OA 的溶栓治疗缺血性脑卒中患者为对照组。在磁共振成像(1.5T 或 3T)或计算机断层扫描上手动勾画缺血性病灶,并将其转换为立体定向空间。我们通过 Liebermeister 检验确定病变重叠,并比较在给定体素中存在或不存在 OA 的患者之间的体素是否存在 OA。采用美国国立卫生研究院脑卒中量表(NIHSS)评分评定脑卒中严重程度,并在入院时测定血压、心率、血糖水平和体温。结果- 共确定了 15 例溶栓相关 OA 的缺血性脑卒中患者。体素分析结果表明,OA 与右半球优势的岛盖区和岛叶区的缺血性病变之间存在相关性。与对照组相比,OA 患者的平均血压明显更低。OA 患者与对照组患者的年龄、NIHSS 评分、梗死体积、心率和血糖水平无差异。结论- 体素分析将溶栓相关 OA 与右岛盖区和岛叶区病变联系起来。溶栓相关 OA 患者的血压较低可能反映了缓激肽的作用,导致血管扩张和增加血管通透性。

相似文献

1
Angioedema in Stroke Patients With Thrombolysis.溶栓治疗的脑卒中患者的血管性水肿。
Stroke. 2019 Jul;50(7):1682-1687. doi: 10.1161/STROKEAHA.119.025260. Epub 2019 Jun 11.
2
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
3
Orolingual angioedema after thrombolysis is not associated with insular cortex ischemia on pre-thrombolysis CT.溶栓后口咽血管性水肿与溶栓前CT上岛叶皮质缺血无关。
J Neurol Sci. 2016 Oct 15;369:48-50. doi: 10.1016/j.jns.2016.07.043. Epub 2016 Jul 20.
4
Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.FLAIR 高信号病灶作为影像生物标志物预测静脉溶栓后动脉内溶栓治疗急性卒中的结局
Cerebrovasc Dis. 2013;35(5):461-8. doi: 10.1159/000350201. Epub 2013 May 31.
5
Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use.急性缺血性脑卒中阿替普酶治疗后口腔-舌血管性水肿:发生率及血管紧张素转换酶抑制剂使用史的风险。
Eur J Neurol. 2014 Oct;21(10):1285-91. doi: 10.1111/ene.12472. Epub 2014 Jun 9.
6
Analysis of related factors of orolingual angioedema after rt-PA intravenous thrombolytic therapy.分析 rt-PA 静脉溶栓治疗后口腔舌血管性水肿的相关因素。
Eur Rev Med Pharmacol Sci. 2018 Mar;22(5):1478-1484. doi: 10.26355/eurrev_201803_14496.
7
Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study.基于磁共振成像的与基于计算机断层扫描的急性缺血性脑卒中溶栓治疗:队列研究中的安全性和疗效比较。
Cerebrovasc Dis. 2013;35(3):250-6. doi: 10.1159/000347071. Epub 2013 Mar 26.
8
Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?急性脑梗死患者既往有颅内出血者是否应排除静脉溶栓治疗?
Int J Stroke. 2016 Oct;11(7):783-90. doi: 10.1177/1747493016654289. Epub 2016 Jun 16.
9
Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke.急性缺血性卒中溶栓治疗期间危及生命的口咽血管性水肿
J Neurol. 2005 Oct;252(10):1167-70. doi: 10.1007/s00415-005-0789-9. Epub 2005 Sep 27.
10
Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.使用扩散加权成像和灌注加权成像监测静脉注射重组组织型纤溶酶原激活剂治疗急性缺血性卒中的溶栓过程。
Stroke. 2000 Jun;31(6):1318-28. doi: 10.1161/01.str.31.6.1318.

引用本文的文献

1
Modulation of miRNAs by Phytochemicals in Cerebral Ischemia: A Systematic Review of In Vitro and In Vivo Studies.植物化学物质对脑缺血中微小RNA的调节作用:一项关于体外和体内研究的系统综述
Phytother Res. 2025 Sep;39(9):4327-4347. doi: 10.1002/ptr.70062. Epub 2025 Aug 13.
2
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment.C1 抑制剂正常的遗传性血管性水肿:关于诊断、病理生理学及治疗的国际最新共识文件
Clin Rev Allergy Immunol. 2025 Mar 7;68(1):24. doi: 10.1007/s12016-025-09027-4.
3
Risk of angioedema and thrombolytic therapy among stroke patients: An analysis of data from the FDA Adverse Event Reporting System database.
中风患者血管性水肿风险与溶栓治疗:来自美国食品药品监督管理局不良事件报告系统数据库的数据分析
Neurotherapeutics. 2025 Jan;22(1):e00474. doi: 10.1016/j.neurot.2024.e00474. Epub 2024 Oct 30.
4
Icatibant averting mechanical ventilation in acute ischemic stroke patient with alteplase-induced orolingual angioedema.艾替班特可避免急性缺血性卒中患者因阿替普酶诱发的口咽血管性水肿而进行机械通气。
Eur J Neurol. 2024 Apr;31(4):e16173. doi: 10.1111/ene.16173. Epub 2023 Dec 28.
5
Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges.缓激肽介导的血管性水肿的神经和精神表现:旧的和新的挑战。
Int J Mol Sci. 2023 Jul 29;24(15):12184. doi: 10.3390/ijms241512184.
6
Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window: A Retrospective Analysis.尿激酶联合静脉重组组织型纤溶酶原激活剂治疗超窗期脑卒中患者的疗效:一项回顾性分析。
Neurologist. 2023 Nov 1;28(6):373-378. doi: 10.1097/NRL.0000000000000499.
7
"Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions.“超级”丝氨酸蛋白酶抑制剂——血栓炎症状态下对抗纤维蛋白溶解的稳定力量。
Front Cardiovasc Med. 2023 Apr 19;10:1146833. doi: 10.3389/fcvm.2023.1146833. eCollection 2023.
8
The predictors of death within 1 year in acute ischemic stroke patients based on machine learning.基于机器学习的急性缺血性卒中患者1年内死亡的预测因素。
Front Neurol. 2023 Feb 23;14:1092534. doi: 10.3389/fneur.2023.1092534. eCollection 2023.
9
6-(Arylaminomethyl) Isoquinolines as Enzyme Inhibitors and Their Preparation: A Patent Highlight of Factor XIIa Inhibitors.作为酶抑制剂的6-(芳基氨基甲基)异喹啉及其制备:凝血因子XIIa抑制剂的专利亮点
Cardiovasc Hematol Agents Med Chem. 2023;21(3):243-249. doi: 10.2174/1871525721666230126114224.
10
Angioedema Secondary to tPA Use in Acute Ischemic Stroke Patient with Hypertension: A Case Report.高血压急性缺血性脑卒中患者使用组织型纤溶酶原激活剂后继发血管性水肿:一例报告
Clin Pract Cases Emerg Med. 2021 May;5(2):159-162. doi: 10.5811/cpcem.2021.1.49582.